LNTH / Is Lantheus (LNTH) Outperforming Other Medical Stocks This Year?

Lantheus Holdings (LNTH) closed at $69.21 in the latest trading session, marking a -1.8% move from the prior day. more_horizontal

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can im more_horizontal

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can im more_horizontal

If you're putting together a list of overlooked AI stocks, I wouldn't try to sneak Nvidia (NASDAQ: NVDA ) on it. Even investor neophytes know about CE more_horizontal

Investors need to pay close attention to Lantheus Holdings (LNTH) stock based on the movements in the options market lately. more_horizontal

Radiopharmacy is expected to experience exponential growth over the next decade. Radiopharmaceutical-based therapies offer more targeted and specific more_horizontal

Zacks.com users have recently been watching Lantheus Holdings (LNTH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's more_horizontal

Lantheus Holdings (LNTH) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares t more_horizontal